Anne Voss

4.7k total citations · 1 hit paper
85 papers, 2.4k citations indexed

About

Anne Voss is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anne Voss has authored 85 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Rheumatology, 33 papers in Immunology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anne Voss's work include Systemic Lupus Erythematosus Research (43 papers), Atherosclerosis and Cardiovascular Diseases (15 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Anne Voss is often cited by papers focused on Systemic Lupus Erythematosus Research (43 papers), Atherosclerosis and Cardiovascular Diseases (15 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Anne Voss collaborates with scholars based in Denmark, United States and Sweden. Anne Voss's co-authors include Howard Sprecher, Shankar K. Sankarappa, Peter Junker, Helle Laustrup, Søren Jacobsen, Peter Garred, Ulrik Tarp, Søren Thue Lillevang, Anders Bengtsson and Christoffer Tandrup Nielsen and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anne Voss

81 papers receiving 2.3k citations

Hit Papers

The metabolism of 7,10,13,16,19-docosapentaenoic acid to ... 1991 2026 2002 2014 1991 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase.
    1991 542 citations Anne Voss et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Voss Denmark 25 1.0k 1.0k 479 361 279 85 2.4k
Norihiko Sakai Japan 34 805 0.8× 407 0.4× 1.0k 2.1× 65 0.2× 316 1.1× 110 3.7k
Stephen H. Powis United Kingdom 34 2.0k 1.9× 278 0.3× 1.5k 3.2× 203 0.6× 192 0.7× 70 4.5k
Yasunori Iwata Japan 28 916 0.9× 458 0.5× 754 1.6× 50 0.1× 230 0.8× 118 3.1k
Chang‐Youh Tsai Taiwan 32 1.2k 1.2× 1.4k 1.4× 812 1.7× 66 0.2× 208 0.7× 190 3.3k
Kathleen Haines United States 26 664 0.6× 498 0.5× 502 1.0× 51 0.1× 250 0.9× 44 2.0k
Volker Vielhauer Germany 36 1.9k 1.8× 878 0.9× 913 1.9× 74 0.2× 389 1.4× 67 4.4k
Claudio Sandoval United States 25 212 0.2× 542 0.5× 784 1.6× 209 0.6× 198 0.7× 92 2.8k
Martti Virolainen Finland 30 465 0.5× 340 0.3× 813 1.7× 198 0.5× 428 1.5× 70 3.4k
Daniel Goldman United States 25 1.1k 1.1× 1.0k 1.0× 453 0.9× 44 0.1× 107 0.4× 64 2.1k
Takuji Naruse Japan 25 275 0.3× 272 0.3× 639 1.3× 118 0.3× 201 0.7× 125 2.0k

Countries citing papers authored by Anne Voss

Since Specialization
Citations

This map shows the geographic impact of Anne Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Voss more than expected).

Fields of papers citing papers by Anne Voss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Voss. The network helps show where Anne Voss may publish in the future.

Co-authorship network of co-authors of Anne Voss

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Voss. A scholar is included among the top collaborators of Anne Voss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Voss. Anne Voss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Linge, Petrus, Julie Brogaard Larsen, Ellen‐Margrethe Hauge, et al.. (2025). Molecular mechanisms underlying thrombosis in systemic lupus erythematosus – A Systematic review. Seminars in Arthritis and Rheumatism. 72. 152707–152707. 1 indexed citations
2.
Larsen, Julie Brogaard, et al.. (2024). Antiphospholipid antibodies and antiphospholipid syndrome. Ugeskrift for Læger. 186(21). 1–8.
3.
Fana, Viktoria, Hanne Lindegaard, Anne Voss, et al.. (2023). The impact of an ultrasound atlas for scoring salivary glands in primary Sjögren’s syndrome: a pilot study. Clinical Rheumatology. 42(12). 3275–3281. 2 indexed citations
4.
5.
Andersen, Martin, Anders Stockmarr, Henrik Leffers, et al.. (2022). Absolute risk estimation of new-onset proteinuria in patients with systemic lupus erythematosus: a Danish nationwide cohort study. Clinical and Experimental Rheumatology. 41(11). 2264–2268. 2 indexed citations
6.
Tan, Eng Hooi, Annika M. Jödicke, Mees Mosseveld, et al.. (2021). The impact of COVID-19 on population-level drug utilization of alendronate. Osteoporosis International. 1 indexed citations
7.
Reid, Sarah, Niklas Hagberg, Johanna K. Sandling, et al.. (2021). Interaction between the STAT4 rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 80(9). 1183–1189. 13 indexed citations
8.
Schreiber, Karen, Savino Sciascia, Ian N Bruce, et al.. (2020). Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians. The Lancet Rheumatology. 2(12). e735–e736. 1 indexed citations
9.
Voss, Anne, et al.. (2019). Spondyloarthritis and Outcomes in Pregnancy and Labor: A Nationwide Register‐Based Cohort Study. Arthritis Care & Research. 73(2). 282–288. 22 indexed citations
10.
Troldborg, Anne, Rudi Steffensen, Marten Trendelenburg, et al.. (2019). Ficolin-3 Deficiency is Associated with Disease and an Increased Risk of Systemic Lupus Erythematosus. Molecular Immunology. 114. 490–490. 11 indexed citations
11.
Troldborg, Anne, Rudi Steffensen, Marten Trendelenburg, et al.. (2019). Ficolin-3 Deficiency Is Associated with Disease and an Increased Risk of Systemic Lupus Erythematosus. Journal of Clinical Immunology. 39(4). 421–429. 19 indexed citations
12.
13.
Poulsen, Mikael Kjær, et al.. (2015). Coronary, Carotid, and Lower-extremity Atherosclerosis and Their Interrelationship in Danish Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology. 43(2). 315–322. 20 indexed citations
14.
Asgari, Nasrin, Anne Voss, Troels Steenstrup, et al.. (2013). Interferon Alpha Association with Neuromyelitis Optica. SHILAP Revista de lepidopterología. 2013. 1–6. 17 indexed citations
15.
Carlsen, Anting Liu, Aaron J. Schetter, Christoffer Tandrup Nielsen, et al.. (2013). Circulating MicroRNA Expression Profiles Associated With Systemic Lupus Erythematosus. Arthritis & Rheumatism. 65(5). 1324–1334. 187 indexed citations
16.
Faurschou, Mikkel, Lene Mellemkjær, H Starklint, et al.. (2011). High Risk of Ischemic Heart Disease in Patients with Lupus Nephritis. The Journal of Rheumatology. 38(11). 2400–2405. 35 indexed citations
17.
Rizzo, Roberta, Thomas Vauvert F. Hviid, Marcello Govoni, et al.. (2008). HLA‐G genotype and HLA‐G expression in systemic lupus erythematosus: HLA‐G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens. 71(6). 520–529. 106 indexed citations
18.
Aaronson, Neil K., Matthew D. Barber, Judith Bauer, et al.. (2003). Effect of a Protein and Energy Dense N-3 Fatty Acid Enriched Oral Supplement on Loss of Weight and Lean Tissue in Cancer Cachexia: A Randomised Double Blind Trial. 5 indexed citations
19.
20.
Voss, Anne, et al.. (1987). Dependence of ATP citrate lyase activity on cell density of isolated rat hepatocytes. Biochemical and Biophysical Research Communications. 149(1). 118–124. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norihiko Sakai Breakdown of academic impact, for papers by Stephen H. Powis Breakdown of academic impact, for papers by Yasunori Iwata Breakdown of academic impact, for papers by Chang‐Youh Tsai Breakdown of academic impact, for papers by Kathleen Haines Breakdown of academic impact, for papers by Volker Vielhauer Breakdown of academic impact, for papers by Claudio Sandoval Breakdown of academic impact, for papers by Martti Virolainen Breakdown of academic impact, for papers by Daniel Goldman Breakdown of academic impact, for papers by Takuji Naruse
Rankless by CCL
2026